Motexafin gadolinium: a novel radiosensitizer for brain tumors Article

Forouzannia, Afshin, Richards, Gregory M, Khuntia, Deepak et al. (2007). Motexafin gadolinium: a novel radiosensitizer for brain tumors . EXPERT REVIEW OF ANTICANCER THERAPY, 7(6), 785-794. 10.1586/14737140.7.6.785

cited authors

  • Forouzannia, Afshin; Richards, Gregory M; Khuntia, Deepak; Mehta, Minesh P

sustainable development goals

authors

publication date

  • June 1, 2007

webpage

published in

keywords

  • CANCER
  • Life Sciences & Biomedicine
  • METASTASES
  • Oncology
  • PHASE-III
  • PROGNOSTIC-FACTORS
  • RADIATION-THERAPY
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • RECURSIVE PARTITIONING ANALYSIS
  • SENSITIZER
  • Science & Technology
  • TEXAPHYRIN
  • brain metastases
  • glioblastoma multiforme
  • motexafin gadolinium
  • neutron capture therapy
  • radiation sensitizers

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 785

end page

  • 794

volume

  • 7

issue

  • 6